抗小鼠OX40单抗（克隆号OX86）引用文献

抗小鼠OX40单克隆抗体（克隆号OX86）引用文献如下：

1. Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes
2. OX40+ plasmacytoid dendritic cells in the tumor microenvironment promote antitumor immunity
3. Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation
4.Activation of OX40 Prolongs and Exacerbates Autoimmune Experimental Uveitis
5.Imaging activated T cells predicts response to cancer vaccines
6.Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells
7.OX40 expression in neutrophils promotes hepatic ischemia/reperfusion injury
8.4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine
9.OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum
10.Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinations
11.Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapy
12.Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models
13.OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccines
14.An OX40/OX40L interaction directs successful immunity to hepatitis B virus
15.OX40 agonist combined with irreversible electroporation synergistically eradicates established tumors and drives systemic antitumor immune response in a syngeneic pancreatic cancer model
16.Whole-body PET imaging of T cell response to Glioblastoma
17.OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
18.FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms
19.New insights on OX40 in the control of T cell immunity and immune tolerance in vivo
20.Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment
……

Syd Labs抗小鼠OX40重组抗体（克隆号OX86）：

Syd Labs 重组抗小鼠OX40单克隆抗体（克隆号OX86），小鼠IgG2a Kappa，体内实验级（In Vivo Grade Recombinant Anti-mouse OX40 Monoclonal Antibody (Clone OX86), Mouse IgG2a Kappa，货号：PA007168.m2a）是用哺乳动物细胞生产的重组抗体，从大鼠抗小鼠OX40单克隆抗体（克隆号：OX86）可变区序列中提取，可用于ELISA，免疫印迹(WB)，免疫荧光(IF)，流式细胞术(FC)，以及各种体外和体内功能测定等研究。

Syd Labs 重组抗小鼠OX40单克隆抗体（克隆号OX86），大鼠IgG1 Kappa，体内实验级（In Vivo Grade Recombinant Anti-mouse OX40 Monoclonal Antibody (Clone OX86), Rat IgG1 Kappa，货号：PA007168.r1）是用哺乳动物细胞生产的重组抗体，从大鼠抗小鼠OX40单克隆抗体（克隆号：OX86）可变区序列中提取，可用于ELISA，免疫印迹(WB)，免疫荧光(IF)，流式细胞术(FC)，以及各种体外和体内功能测定等研究。

如果需要了解更多有关Syd Labs 重组抗小鼠OX40单克隆抗体(克隆号OX86)信息，比如Syd Labs 抗小鼠OX40单抗使用说明等资料，欢迎联系多找找获取。

特此声明：多找找推广的所有产品和服务的价格、货期和规格等信息如有更改，恕不另行通知。除非另有说明，多找找推广的所有目录和定制产品仅限于科研使用，不得用于人类或动物的诊断或治疗。